查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1593907

MRI顯影劑市場：按產品、給藥途徑、應用和最終用戶 - 全球預測 2025-2030

MRI Contrast Media Agents Market by Product (Paramagnetic Contrast Agents, Supermagnetic Contrast Agent), Route of Administration (Injection, Oral), Application, End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年MRI顯影劑市場規模為25億美元，預計2024年將達26.7億美元，複合年成長率為7.54%，2030年將達到41.6億美元。

MRI顯影劑是用於提高磁振造影(MRI) 掃描品質並可以更準確地診斷和評估醫療狀況的特殊試劑。這些钆基藥物改變水分子的磁性，提高內部結構、組織和異常的可見度。這些試劑的需求源自於診斷過程中對高解析度成像的需求，特別是用於檢測腫瘤、發炎和血管疾病。應用廣泛應用於神經病學、心臟病學、腫瘤學和肌肉骨骼成像。最終用途主要是醫院、診斷影像中心和研究機構。

主要市場統計
基準年[2023] 25億美元
預測年份 [2024] 26.7億美元
預測年份 [2030] 41.6億美元
複合年成長率（%） 7.54%

由於慢性病的增加、MRI 技術的進步以及對微創診斷程序的需求不斷成長，MRI顯影劑市場正在蓬勃發展。此外，人口老化和醫療保健支出的增加正在推動市場成長。開發非钆基藥物和新製劑的機會很多，有望使腎功能不全或過敏患者輕鬆排泄。為了利用這些優勢，公司應該投資於旨在提高安全性和擴大應用範圍的研發活動。

然而，挑戰仍然存在，包括嚴格的監管要求、高昂的影像處理成本以及有關钆保留的安全問題。來自電腦斷層掃描等替代顯像模式和人工智慧影像分析等新技術的競爭也可能阻礙成長。此外，在某些地區，先進的 MRI 技術的使用受到限制，從而限制了市場的擴張。

在技​​術創新方面，生物分解性和顯影劑顯影劑的探索提供了一條充滿希望​​的道路。專注於減少副作用和增強目標特異性的研究也可能推動成長。複雜的監管環境要求市場相關人員適應不斷變化的指導方針，以維持合規性和市場地位。總體而言，該市場即將成長，但充分發揮其潛力需要在技術、經濟和監管挑戰之間進行策略性導航。

市場動態：揭示快速發展的 MRI顯影劑市場的關鍵市場洞察

供需的動態交互作用正在改變 MRI顯影劑市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 慢性病盛行率上升
    • 診斷中心和醫院數量的增加
    • 顯影劑的核准增加
  • 市場限制因素
    • MRI顯影劑高成本
  • 市場機會
    • 採用技術先進的 MRI顯影劑
    • 提高早期診斷意識
  • 市場問題
    • 低度開發國家難以獲得先進治療

波特五力：駕馭 MRI顯影劑市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢、解決弱點並避免潛在的挑戰，以確保更強大的市場地位。

PESTLE分析：了解 MRI顯影劑市場的外部影響

外部宏觀環境因素在塑造 MRI顯影劑市場的表現動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解 MRI顯影劑市場的競爭格局

對 MRI顯影劑市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：MRI顯影劑市場供應商的績效評估

FPNV定位矩陣是評估MRI顯影劑市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製 MRI顯影劑市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對 MRI顯影劑市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭格局中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：詳細檢視當前市場環境，主要企業的廣泛資料，評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、主要產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 慢性病盛行率上升
      • 診斷中心和醫院的增加
      • 顯影劑的核准增加
    • 抑制因素
      • MRI顯影劑成本高
    • 機會
      • 採用技術先進的 MRI顯影劑
      • 提高早期診斷意識
    • 任務
      • 在開發中國家獲得先進治療方法的困難
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章 MRI顯影劑市場：依產品

  • 介紹
  • 順磁性顯影劑
    • 血池顯影劑
    • 細胞外液
    • 器官特異性藥物
  • 超磁顯影劑

第7章 MRI顯影劑市場：依給藥途徑

  • 介紹
  • 注射
  • 口服

第8章 MRI顯影劑市場：依應用分類

  • 介紹
  • 胃腸道
  • 肝膽系統
  • 靜脈
  • 神經影像診斷

第 9 章 MRI顯影劑

  • 介紹
  • 門診手術中心
  • 診斷中心
  • 醫院

第10章 美洲MRI顯影劑市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太地區MRI顯影劑市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲MRI顯影劑市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Acro Lifesciences（I）Pvt. Ltd.
  • Bayer AG
  • Beijing Beilu Pharmaceutical Co., Ltd.
  • Bracco Imaging SpA
  • Daiichi Sankyo Company, Limited
  • General Electric Company
  • Guerbet SA
  • iMAX Diagnostic Imaging Limited
  • Lantheus Medical Imaging, Inc.
  • Miltenyi BIoTec BV & Co. KG
  • Nano Therapeutics Pvt. Ltd. by Serum Institute of India Pvt. Ltd.
  • SANOCHEMIA Pharmazeutika GmbH
  • Spago Nanomedical AB
  • Trivitron Healthcare
  • Vitalquan, LLC
Product Code: MRR-F927BA46208C

The MRI Contrast Media Agents Market was valued at USD 2.50 billion in 2023, expected to reach USD 2.67 billion in 2024, and is projected to grow at a CAGR of 7.54%, to USD 4.16 billion by 2030.

MRI contrast media agents are specialized drugs used to enhance the quality of magnetic resonance imaging (MRI) scans, enabling more accurate diagnosis and assessment of medical conditions. These agents, primarily gadolinium-based, alter the magnetic properties of water molecules, improving the visibility of internal structures, tissues, and abnormalities. Their necessity stems from the need for high-resolution images in diagnostic procedures, particularly for detecting tumors, inflammation, and vascular disease. Application-wise, they are extensively utilized in neurology, cardiology, oncology, and musculoskeletal imaging. End-use primarily spans hospitals, diagnostic imaging centers, and research institutions.

KEY MARKET STATISTICS
Base Year [2023] USD 2.50 billion
Estimated Year [2024] USD 2.67 billion
Forecast Year [2030] USD 4.16 billion
CAGR (%) 7.54%

The market for MRI contrast media agents is buoyed by increasing incidences of chronic diseases, advancements in MRI technology, and growing demand for minimally invasive diagnostic procedures. Additionally, the aging population and rising healthcare expenditure are driving market growth. Opportunities abound in the development of non-gadolinium-based agents and novel formulations that promise easier excretion, catering to patients with renal impairment or allergies. To capitalize on these, businesses should invest in R&D activities aimed at enhancing safety profiles and broadening application scopes.

However, challenges persist, such as stringent regulatory requirements, high costs of imaging procedures, and safety concerns related to gadolinium retention. Competition from alternative imaging modalities, like CT scans, and emerging technologies, such as AI-driven imaging analyses, could also hamper growth. Moreover, certain regions face limited access to advanced MRI technology, constraining market expansion.

For innovation, exploration into biodegradable and non-metallic contrast agents presents a promising avenue. Research focusing on reducing adverse reactions and enhancing target specificity could also spur growth. The intricate regulatory landscape necessitates that market players stay aligned with evolving guidelines to maintain compliance and market presence. Overall, the market is poised for growth but requires strategic navigation amidst technological, economic, and regulatory challenges to fully harness its potential.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving MRI Contrast Media Agents Market

The MRI Contrast Media Agents Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of chronic disorders
    • Growing number of diagnostic centers and hospitals
    • Increasing approvals of contrast agents
  • Market Restraints
    • High cost of MRI contrast media agents
  • Market Opportunities
    • Introduction of technologically advanced MRI contrast agents
    • Increasing awareness regarding early diagnosis
  • Market Challenges
    • Inaccessibility of advanced therapeutics in underdeveloped countries

Porter's Five Forces: A Strategic Tool for Navigating the MRI Contrast Media Agents Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the MRI Contrast Media Agents Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the MRI Contrast Media Agents Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the MRI Contrast Media Agents Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the MRI Contrast Media Agents Market

A detailed market share analysis in the MRI Contrast Media Agents Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the MRI Contrast Media Agents Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the MRI Contrast Media Agents Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the MRI Contrast Media Agents Market

A strategic analysis of the MRI Contrast Media Agents Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the MRI Contrast Media Agents Market, highlighting leading vendors and their innovative profiles. These include Acro Lifesciences (I) Pvt. Ltd., Bayer AG, Beijing Beilu Pharmaceutical Co., Ltd., Bracco Imaging S.p.A, Daiichi Sankyo Company, Limited, General Electric Company, Guerbet SA, iMAX Diagnostic Imaging Limited, Lantheus Medical Imaging, Inc., Miltenyi Biotec B.V. & Co. KG, Nano Therapeutics Pvt. Ltd. by Serum Institute of India Pvt. Ltd., SANOCHEMIA Pharmazeutika GmbH, Spago Nanomedical AB, Trivitron Healthcare, and Vitalquan, LLC.

Market Segmentation & Coverage

This research report categorizes the MRI Contrast Media Agents Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Paramagnetic Contrast Agents and Supermagnetic Contrast Agent. The Paramagnetic Contrast Agents is further studied across Blood Pool Contrast Agents, Extracellular Fluid Agents, and Organ-Specific Agents.
  • Based on Route of Administration, market is studied across Injection and Oral.
  • Based on Application, market is studied across Gastrointestinal, Hepatobiliary, Intravenous, and Neurological Imaging.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Diagnostic Centers, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of chronic disorders
      • 5.1.1.2. Growing number of diagnostic centers and hospitals
      • 5.1.1.3. Increasing approvals of contrast agents
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of MRI contrast media agents
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of technologically advanced MRI contrast agents
      • 5.1.3.2. Increasing awareness regarding early diagnosis
    • 5.1.4. Challenges
      • 5.1.4.1. Inaccessibility of advanced therapeutics in underdeveloped countries
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. MRI Contrast Media Agents Market, by Product

  • 6.1. Introduction
  • 6.2. Paramagnetic Contrast Agents
    • 6.2.1. Blood Pool Contrast Agents
    • 6.2.2. Extracellular Fluid Agents
    • 6.2.3. Organ-Specific Agents
  • 6.3. Supermagnetic Contrast Agent

7. MRI Contrast Media Agents Market, by Route of Administration

  • 7.1. Introduction
  • 7.2. Injection
  • 7.3. Oral

8. MRI Contrast Media Agents Market, by Application

  • 8.1. Introduction
  • 8.2. Gastrointestinal
  • 8.3. Hepatobiliary
  • 8.4. Intravenous
  • 8.5. Neurological Imaging

9. MRI Contrast Media Agents Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Diagnostic Centers
  • 9.4. Hospitals

10. Americas MRI Contrast Media Agents Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific MRI Contrast Media Agents Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa MRI Contrast Media Agents Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Acro Lifesciences (I) Pvt. Ltd.
  • 2. Bayer AG
  • 3. Beijing Beilu Pharmaceutical Co., Ltd.
  • 4. Bracco Imaging S.p.A
  • 5. Daiichi Sankyo Company, Limited
  • 6. General Electric Company
  • 7. Guerbet SA
  • 8. iMAX Diagnostic Imaging Limited
  • 9. Lantheus Medical Imaging, Inc.
  • 10. Miltenyi Biotec B.V. & Co. KG
  • 11. Nano Therapeutics Pvt. Ltd. by Serum Institute of India Pvt. Ltd.
  • 12. SANOCHEMIA Pharmazeutika GmbH
  • 13. Spago Nanomedical AB
  • 14. Trivitron Healthcare
  • 15. Vitalquan, LLC

LIST OF FIGURES

  • FIGURE 1. MRI CONTRAST MEDIA AGENTS MARKET RESEARCH PROCESS
  • FIGURE 2. MRI CONTRAST MEDIA AGENTS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. MRI CONTRAST MEDIA AGENTS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. MRI CONTRAST MEDIA AGENTS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MRI CONTRAST MEDIA AGENTS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MRI CONTRAST MEDIA AGENTS MARKET DYNAMICS
  • TABLE 7. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY BLOOD POOL CONTRAST AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY EXTRACELLULAR FLUID AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ORGAN-SPECIFIC AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY SUPERMAGNETIC CONTRAST AGENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY INJECTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY GASTROINTESTINAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY HEPATOBILIARY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY INTRAVENOUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY NEUROLOGICAL IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. ARGENTINA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 37. BRAZIL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. CANADA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. MEXICO MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. UNITED STATES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 58. ASIA-PACIFIC MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 64. AUSTRALIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. CHINA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. INDIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. INDONESIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. JAPAN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. MALAYSIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. PHILIPPINES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. SINGAPORE MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. SOUTH KOREA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. TAIWAN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. THAILAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. VIETNAM MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 130. DENMARK MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 135. EGYPT MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. FINLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. FRANCE MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. GERMANY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. ISRAEL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. ITALY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. NETHERLANDS MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. NIGERIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. NORWAY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. POLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. QATAR MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. RUSSIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. SAUDI ARABIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. SOUTH AFRICA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. SPAIN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. SWEDEN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. SWITZERLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 220. TURKEY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. UNITED ARAB EMIRATES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED KINGDOM MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY PARAMAGNETIC CONTRAST AGENTS, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM MRI CONTRAST MEDIA AGENTS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. MRI CONTRAST MEDIA AGENTS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 236. MRI CONTRAST MEDIA AGENTS MARKET, FPNV POSITIONING MATRIX, 2023